JP Morgan Chase
ROIV icon

JP Morgan Chase’s Roivant Sciences ROIV Stock Holding History

JP Morgan Chase’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-78,900
Closed -$2.08M – 8025
2026
Q1 		$2.08M Hold
78,900
– – ﹤0.01% 4072
2025
Q4 		$1.71M Sell
78,900
-5,000
-6% -$98.6K ﹤0.01% 4204
2025
Q3 		$1.27M Buy
+83,900
New +$1.04M ﹤0.01% 4415
2023
Q4 		– Sell
-200,000
Closed -$2.34M – 7825
2023
Q3 		$2.34M Buy
200,000
+158,400
+381% +$1.79M ﹤0.01% 3442
2023
Q2 		$419K Buy
+41,600
New +$372K ﹤0.01% 4597

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

JP Morgan Chase's ROIV Position: Q2 2026 in Review

JP Morgan Chase reduced its Roivant Sciences (ROIV) stake by 26% in Q2 2026, selling an estimated $11.8M and leaving 1,137,867 shares worth $40.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1635.

JP Morgan Chase first reported a position in ROIV in Q2 2022 and has held it in 17 quarters since. The position peaked at $40.6M in Q1 2026. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • JP Morgan Chase held 1,137,867 shares of Roivant Sciences worth $40.3M as of Q2 2026.
  • JP Morgan Chase sold 399,652 Roivant Sciences shares in Q2 2026, an estimated $11.8M.
  • Roivant Sciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1635 holding.
  • JP Morgan Chase first reported a position in Roivant Sciences in Q2 2022 and has held it in 17 quarters since.
  • JP Morgan Chase's Roivant Sciences position peaked at $40.6M in Q1 2026.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.